Imbruvica (Ibrutinib) Capsule

Imbruvica Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Imbruvica Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections. It may cause headache, diarrhea, and nausea as its side effects.

Uses Of Imbruvica Capsule

• Mantle-cell lymphoma
• Blood cancer (Chronic lymphocytic leukemia)

Side Effects Of Imbruvica Capsule

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common Side Effects Of Imbruvica

• Headache
• Joint pain
• Fever
• Diarrhea
• Vomiting
• Stomatitis (Inflammation of the mouth)
• Nausea
• Constipation
• Low blood platelets
• Decreased white blood cell count (neutrophils)
• Upper respiratory tract infection

How To Use Imbruvica Capsule

Take this medicine in the dose and duration as advised by your doctor. Imbruvica Capsule may be taken with or without food, but it is better to take it at a fixed time.

How Imbruvica Capsule Works

Imbruvica Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.